Ligation Devices Market

Global Ligation Devices Market Size (2023 to 2028)

The global market for ligation devices is estimated to grow at a CAGR of 7.22% from 2023 to 2028. The market was valued at USD 1048.4 million in 2023 and is forecasted to be USD 1485.6 million by 2028.

Ligation is a surgical operation consisting of tying a ligature around a body conduit, a tube, or a blood artery using string or a wire. Esophageal varices are bandaged using ligation devices. Various other attachments include band ligators which altogether remove the developed hemorrhoids. Bulging lesions can be effectively treated with endoscopic ligation, which is also frequently used to treat angiodysplasia, gastric varices, and esophageal hemorrhage. Therefore, eliminating lesions in the upper gastrointestinal system is a practical strategy. Additionally, it lessens the chance of complications, including bleeding and perforation. The growth of hemorrhoids, gastrointestinal appendages, left atrial appendages, and ureteral blockage brought on by cardinal ligaments are only a few disorders that can benefit from its use in their therapy.

Impact of COVID-19 on the global ligation devices market:

The outbreak began in March 2020 and continued for over a year. The lockdowns and quarantines resulted from the coronavirus outbreak in China. Many businesses have suffered losses due to shipping restrictions. As more deaths were reported, the unemployment rate rose. Due to the unexpected increase in the number of patients and the severe shortage of hospital resources, such as oxygen cylinders and beds, the financial situation has deteriorated. The susceptibility of patients undergoing surgery to be exposed to COVID-19 would hamper the growth of the ligation devices market. In addition, the unprecedented effects have led to fewer elective operations, such as tubal ligation. Since this operation requires general anesthesia and intubation, there is an increased risk of spreading the virus through airborne droplets. The prevalence of gastrointestinal problems in critically sick patients, such as food intolerance to mesenteric ischemia, may increase the need for ligation procedures for ischemia and other gastrointestinal infections.

MARKET DRIVERS:

Increasing patient preference for minimally invasive surgery due to shorter hospital stays and fewer complications will be an essential factor. In addition, the rising prevalence of conditions such as bulging gastrointestinal lesions, angiodysplasia, gastric varices, and an increase in bariatric and cosmetic surgeries is expected to accelerate the growth rate of the ligation devices market over the forecast period. Furthermore, in the following years, the ligation devices market is expected to grow further owing to the enormous demand for minimally invasive treatments employing ligation devices and accessories and rising healthcare costs for treating different cardiovascular illnesses and other ailments.

Precision ablation using vascular ligation devices to augment the market growth.

Companies in the ligation device market are honing their technology and engineering skills and focusing on helping healthcare professionals gain a good understanding of tissues during surgeries to improve medical outcomes. This helps healthcare professionals perform precise ultrasound-guided ablation. For example, Novus, one of the forerunners of direct therapeutic ultrasound technology, is concentrating on developing its vascular ligation device, which can use ultrasonic waves to quickly and precisely ablate tissue to enhance hemostatic control.

TeachMeSurgery data show that about 6% of lower gastrointestinal hemorrhage and more than 8% of upper gastrointestinal bleeding are caused by a typical gastrointestinal vascular anomaly. This aspect will contribute to the segment's continued expansion in the coming years, along with the rising use of truncal vagotomy and suture ligation to treat upper gastrointestinal bleeding in geriatric patients experiencing hemorrhage and shock. Also, the increasing prevalence of cervical and ovarian cancers requiring ligation devices for treatment is expected to drive the market down significantly.

MARKET RESTRAINTS:

Factors such as lack of skilled professionals, absence of awareness, high costs associated with the devices, and higher investments requiring surgical procedures are anticipated to hinder the growth rate of the ligation devices market. Additionally, side effects of tubal ligation surgery, such as pelvic or abdominal pain, are other notable factors anticipated to showcase a negative impact on the growth of ligation devices. Also, the cost of ligation and other surgical devices is relatively high, putting a significant financial strain on the healthcare system and the patient. Furthermore, government programs and insurance companies only cover a portion of the costs, restraining the market's growth.

REPORT COVERAGE:

This research report on the global ligation devices market has been segmented and sub-segmented based on product, application, procedure type, end-user & region.

Ligation Devices Market – By Product:

• Handheld instruments
• Accessories

Based on the product, the accessories segment led the market with more than 50% of the share in 2022. In open and laparoscopic surgical procedures, ligation accessories are applied in bandage esophageal varices. In addition, ligation devices, such as band ligators, are also used with attachments, which remove the developed hemorrhoids.

On the other hand, the handheld instruments segment is also anticipated to register a healthy CAGR during the forecast period. Due to the dramatic increase in cancer incidence and the need to decrease pregnancy rates through surgical ligation, new portable devices have been created to overcome the technical challenges. They provide enhanced functionality in addition to precisely driven and articulated instrument tips. The majority of portable gadgets were created for laparoscopic surgery.

Ligation Devices Market – By Application:

• Gastrointestinal & Abdominal Surgeries
• Gynecological Surgeries
• Cardiovascular Surgeries
• Urological Surgeries

Based on application, the gastrointestinal and abdominal surgery segment is also anticipated to rule the market during the forecast period. The large market is mainly linked to the rise in gastrointestinal diagnostic and treatment procedures and the development of age-related disorders. The primary endoscopic method for treating acute bleeding esophageal varices is endoscopic band ligation (EBL). Technically easier to carry out than alternative techniques, this one provides a clear view of the lesions while applying direct pressure and aspirating the transparent ligation cap.

The cardiovascular surgeries segment is expected to witness the fastest growth during the forecast period. Increased adoption of a sedentary lifestyle leads to an increased incidence of cardiovascular diseases. This, in turn, makes way for a rise in the risk of heart disease. As a result, ligation devices are employed during open surgery to unblock blocked arteries or fix a damaged heart valve. In addition, left atrial appendage closure is frequently advised for patients with atrial fibrillation. Because open heart surgery is not necessary for the pericardial ligation operation, there are fewer postoperative problems. Furthermore, in the upcoming years, the segment's growth will be aided by further development in robotic cardiovascular surgery.

Ligation Devices Market – By End-User:

• Hospitals
• Ambulatory surgical centers
• Nursing homes

Based on the end-user, the hospital segment is presumed to dominate the global market by end users. The significant factors expected to drive this segment's growth are an increase in the number of patients preferring hospitals, along with increased investment by hospitals in improving surgical procedures and related ligation accessories.

The Ambulatory Surgical Centers (ASC) segment is also expected to capture a significant market share during the forecast period. The cost savings of 20% to 50% at ASCs compared to the cost to do the same surgery in hospitals and the rising use of minimally invasive surgeries are factors influencing the high growth.

Ligation Devices Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, North America accounted for the leading share of the global ligation devices market in 2022 and is anticipated to lead the market throughout the forecast period. An increasing number of research partnerships increased cardiovascular and urological diseases such as chronic kidney disease, and critical players who established health infrastructures and beneficial government initiatives propelled the market growth.

The ligation devices market in the Asia-Pacific region is anticipated to grow the fastest among all the regions in the global market during the forecast period. The significant growth rate in Asia-Pacific is mainly related to the region's large patient population, excellent infrastructural development, and rising prevalence of gastrointestinal disorders that can be treated with minimally invasive methods employing ligation devices. Many Asian businesses concentrate on creating specific GI products and go after developing nations. Numerous endoscopic procedures require these devices.

Following several programs like EU4Health to strengthen the resilience of healthcare systems in the region, Europe is anticipated to emerge as a lucrative income pocket for the ligation devices market. Furthermore, according to the European Cancer Information System, more than 12.7% of all new cancer diagnoses in the EU-27 nations in 2020 were for colorectal cancer. These elements might encourage ligation devices in laparoscopic colorectal surgery shortly.

The ligation devices market in the Middle East and Africa is driven by factors such as a rise in demand with investment in research and development, an increase in healthcare expenditures in both developed and emerging countries, a growing geriatric population, increasing technological advancements, and growing prevalence of minimally invasive procedures. As a result, manufacturers in the area ought to get a competitive edge and produce cutting-edge ligation devices.

KEY MARKET PARTICIPANTS:

Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, and Genicon, Inc. are some of the noteworthy companies operating in the global ligation devices market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• In October 2022, one of the world's top medical equipment manufacturers, Teleflex Incorporated, made cutting-edge power stapling technology for bariatric surgery commercially available. As a result, standard Bariatrics offers cutting-edge surgical techniques that improve bariatric surgery results.
• In August 2022, Healthium, a global medical device company, announced the successful acquisition of the AbGel gelatin sponge business, which has hemostatic capabilities and is designed to control blood exudation.